United States · Bill · HR
H.R. 3391 (115th)
Medical Marijuana Research Act of 2017
Introduced
25 July 2017
Last action
—
Status
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Medical Marijuana Research Act of 2017 This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 25 July 2017
Introduced in House (PDF)
Introduced in House · EN · 25 July 2017
Introduced in House
summary · EN · 25 July 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/house-bill/3391
- Open data entity: https://api.congress.gov/v3/bill/115/hr/3391